Evidence map›Paper›PMID 17690213›Full record

ArticleThe Journal of molecular diagnostics : JMD2007

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.

Fengfei Wang, Lilin Wang, Christine Briggs, Ewa Sicinska, Sandra M Gaston, Harvey Mamon, Matthew H Kulke, Raffaella Zamponi, Massimo Loda, Elizabeth Maher and 5 more

Abstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Artificial intelligence-augmented histopathologic review using image analysis to optimize DNA yield from formalin-fixed paraffin-embedded slides.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  6. Review
  7. Article
  8. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2022
    Article
  9. Article
  10. Do Tissues Fixed in a Non-crosslinking Fixative Require a Dedicated Formalin-free Processor?The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fengfei WangDepartment of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Lilin Wang
Christine Briggs
Ewa Sicinska
Sandra M Gaston
Harvey Mamon
Matthew H Kulke
Raffaella Zamponi
Massimo Loda
Elizabeth Maher
Shuji Ogino
Charles S Fuchs
Jin Li
Carlos Hader
G Mike Makrigiorgos

Funding

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI GARRAWAY, LEVI A. · 2002 to 2017
$36.2M
Transgenic Mouse CoreP01CA089021 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CANTLEY, LEWIS C. · 2001 to 2011
$20.1M
RADIATION BIOLOGY TRAINING PROGRAMT32CA009078 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI D'ANDREA, ALAN D. · 1985 to 2009
$4.6M
CIRCULATING DNA AMPLIFICATION & COLON CA DETECTIONR21CA115439 · NCI · DANA-FARBER CANCER INST · PI MAKRIGIORGOS, G. M · 2006 to 2007
$353k
GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATIONR21CA111994 · NCI · DANA-FARBER CANCER INSTITUTE · PI MAKRIGIORGOS, G. MIKE · 2005 to 2006
$290k
NCI NIH HHS 1R21 CA111994-01NCI NIH HHS 1R21 CA115439-01A1NCI NIH HHS 5P50 CA90381NCI NIH HHS 5T32 CA09078NCI NIH HHS P01 CA089021NCI NIH HHS P50 CA090381NCI NIH HHS R21 CA111994NCI NIH HHS R21 CA115439NCI NIH HHS T32 CA009078
6 · The paper itself

Abstract

The need to apply modern technologies to analyze DNA from diverse clinical samples often stumbles on suboptimal sample quality. We developed a simple approach to assess DNA fragmentation in minute clinical samples of widely different origin and the likelihood of success of degradation-tolerant whole genome amplification (restriction and circularization-aided rolling circle amplification, RCA-RCA) and subsequent polymerase chain reaction (PCR). A multiplex PCR amplification of four glyceraldehyde-3-phosphate dehydrogenase amplicons of varying sizes was performed using genomic DNA from clinical samples, followed by size discrimination on agarose gel or fluorescent denaturing high-performance liquid chromatography (dHPLC). RCA-RCA followed by real-time PCR was also performed, for correlation. Even minimal quantities of longer PCR fragments ( approximately 300 to 400 bp), visible via high-sensitivity fluorescent dHPLC or agarose gel, were essential for the success of RCA-RCA and subsequent PCR-based assays. dHPLC gave a more accurate correlation between DNA fragmentation and sample quality than agarose gel electrophoresis. Multiplex-PCR-dHPLC predicted correctly the likelihood of assay success in formalin-fixed, paraffin-embedded samples fixed under controlled conditions and of different ages, in laser capture microdissection samples, in tissue print micropeels, and plasma-circulating DNA. Estimates of the percent information retained relative to snap-frozen DNA are derived for real-time PCR analysis. The assay is rapid and convenient and can be used widely to characterize DNA from any clinical sample of unknown quality.

Indexed as

DNA FragmentationBase SequenceDNA, NeoplasmFormaldehydeGenome, HumanGlyceraldehyde-3-Phosphate DehydrogenasesHumansMaleNucleic Acid Amplification TechniquesPolymerase Chain ReactionTemperatureTime FactorsTissue FixationDNA, NeoplasmFormaldehydeGlyceraldehyde-3-Phosphate Dehydrogenases

Identifiers

PMID17690213
PMCPMC1975106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.